The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Clinical Classification of Age-related Macular Degeneration
Open accessAbstract
Objective: To develop a clinical classification system for age-related macular degeneration (AMD). Design: Evidence-based investigation, using a modified Delphi process. Participants: Twenty-six AMD experts, 1 neuro-ophthalmologist, 2 committee chairmen, and 1 methodologist. Methods: Each committee member completed an online assessment of statements summarizing current AMD classification criteria, indicating agreement or disagreement with each statement on a 9-step scale. The group met, reviewed the survey results, discussed the important components of a clinical classification system, and defined new data analyses needed to refine a classification system. After the meeting, additional data analyses from large studies were provided to the committee to provide risk estimates related to the presence of various AMD lesions. Main Outcome Measures: Delphi review of the 9-item set of statements resulting from the meeting. Results: Consensus was achieved in generating a basic clinical classification system based on fundus lesions assessed within 2 disc diameters of the fovea in persons older than 55 years. The committee agreed that a single term, age-related macular degeneration, should be used for the disease. Persons with no visible drusen or pigmentary abnormalities should be considered to have no signs of AMD. Persons with small drusen (<63 μm), also termed drupelets, should be considered to have normal aging changes with no clinically relevant increased risk of late AMD developing. Persons with medium drusen (≥63–<125 μm), but without pigmentary abnormalities thought to be related to AMD, should be considered to have early AMD. Persons with large drusen or with pigmentary abnormalities associated with at least medium drusen should be considered to have intermediate AMD. Persons with lesions associated with neovascular AMD or geographic atrophy should be considered to have late AMD. Five-year risks of progressing to late AMD are estimated to increase approximately 100 fold, ranging from a 0.5% 5-year risk for normal aging changes to a 50% risk for the highest intermediate AMD risk group. Conclusions: The proposed basic clinical classification scale seems to be of value in predicting the risk of late AMD. Incorporating consistent nomenclature into the practice patterns of all eye care providers may improve communication and patient care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of Age-Related Macular Degeneration in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,736
(2001) · Defense Technical Information Center (DTIC) · Cited by 2,158
CANNON, B., & by Stewart Duke-Elder, E. (1973) · Plastic and Reconstructive Surgery · doi:10.1097/00006534-197311000-00020 · Cited by 1,982
Bird, A. C., Bressler, N. M., Bressler, S. B., Chisholm, I. H., Coscas, G., Davis, M. D., de Jong, P. T. V. M., Klaver, C. C. W., Klein, B. E. K., Klein, R., et al. (1995) · Survey of Ophthalmology · doi:10.1016/s0039-6257(05)80092-x · Cited by 1,926
Self-citationA Simplified Severity Scale for Age-Related Macular Degeneration: AREDS Report No. 18
(2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.11.1570 · Cited by 807
(2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.11.1484 · Cited by 739
Fifteen-Year Cumulative Incidence of Age-Related Macular Degeneration
Klein, R., Klein, B. E. K., Knudtson, M. D., Meuer, S. M., Swift, M., & Gangnon, R. E. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.10.040 · Cited by 638
Incidence and progression rates of age-related maculopathy: the Rotterdam Study.
Klaver, C. C. W., Assink, J. J. M., van Leeuwen, R., Wolfs, R. C. W., Vingerling, J. R., Stijnen, T., Hofman, A., & de Jong, P. T. (2001) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 353
The anatomy of the visual system
Duke-Elder, S., & Wybar, K. C. (1961) · Henry Kimpton eBooks · Cited by 339
The Risk and Natural Course of Age-Related Maculopathy: Follow-up at 6½ Years in the Rotterdam Study
van Leeuwen, R. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.4.519 · Cited by 332
Cited by
Age-related macular degeneration
Mitchell, P., Liew, G., Gopinath, B., & Wong, T. Y. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31550-2 · Cited by 1,511
Global Consensus on Keratoconus and Ectatic Diseases
Gomes, J. A. P., Tan, D., Rapuano, C. J., Belin, M. W., Ambrósio, R., Guell, J. L., Malecaze, F., Nishida, K., & Sangwan, V. S. (2015) · Cornea · doi:10.1097/ico.0000000000000408 · Cited by 1,132
Kashani, A. H., Chen, C.-L., Gahm, J. K., Zheng, F., Richter, G. M., Rosenfeld, P. J., Shi, Y., & Wang, R. K. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.07.002 · Cited by 1,006
Age-related macular degeneration
Fleckenstein, M., Keenan, T. D. L., Guymer, R. H., Chakravarthy, U., Schmitz-Valckenberg, S., Klaver, C. C., Wong, W. T., & Chew, E. Y. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00265-2 · Cited by 978
Self-citationConsensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT
Sadda, S. R., Guymer, R., Holz, F. G., Schmitz-Valckenberg, S., Curcio, C. A., Bird, A. C., Blodi, B. A., Bottoni, F., Chakravarthy, U., Chew, E. Y., et al. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2017.09.028 · Cited by 922
Self-citationConsensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data
Spaide, R. F., Jaffe, G. J., Sarraf, D., Freund, K. B., Sadda, S. R., Staurenghi, G., Waheed, N. K., Chakravarthy, U., Rosenfeld, P. J., Holz, F. G., et al. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2019.11.004 · Cited by 824
Self-citationThe Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Fleckenstein, M., Mitchell, P., Freund, K. B., Sadda, S., Holz, F. G., Brittain, C., Henry, E. C., & Ferrara, D. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2017.08.038 · Cited by 561
Self-citationGrassmann, F., Mengelkamp, J., Brandl, C., Harsch, S., Zimmermann, M. E., Linkohr, B., Peters, A., Heid, I. M., Palm, C., & Weber, B. H. F. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2018.02.037 · Cited by 549
Age-Related Macular Degeneration: A Review
Fleckenstein, M., Schmitz-Valckenberg, S., & Chakravarthy, U. (2024) · JAMA · doi:10.1001/jama.2023.26074 · Cited by 549
Self-citationAge-Related Macular Degeneration: Genetics and Biology Coming Together
Fritsche, L. G., Fariss, R. N., Stambolian, D., Abecasis, G. R., Curcio, C. A., & Swaroop, A. (2014) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090413-025610 · Cited by 534
Deep learning in ophthalmology: The technical and clinical considerations
Ting, D. S. W., Peng, L., Varadarajan, A. V., Keane, P. A., Burlina, P. M., Chiang, M. F., Schmetterer, L., Pasquale, L. R., Bressler, N. M., Webster, D. R., et al. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.04.003 · Cited by 534
Age-related macular degeneration
Guymer, R. H., & Campbell, T. G. (2023) · The Lancet · doi:10.1016/s0140-6736(22)02609-5 · Cited by 502
Holz, F. G., Strauss, E. C., Schmitz-Valckenberg, S., & van Lookeren Campagne, M. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.11.023 · Cited by 402
A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration
Schmidt-Erfurth, U., & Waldstein, S. M. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.07.007 · Cited by 390
“Such grading schemes have also been shown to provide a clinically useful risk assessment that may surpass even the precision of genetic testing (Ferris et al., 2013; Stone, 2015).”
BackgroundRisk factors for progression of age‐related macular degeneration
Heesterbeek, T. J., Lorés‐Motta, L., Hoyng, C. B., Lechanteur, Y. T. E., & den Hollander, A. I. (2020) · Ophthalmic and Physiological Optics · doi:10.1111/opo.12675 · Cited by 392
Li, J. Q., Welchowski, T., Schmid, M., Mauschitz, M. M., Holz, F. G., & Finger, R. P. (2020) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2019-314422 · Cited by 381
Peng, Y., Dharssi, S., Chen, Q., Keenan, T. D., Agrón, E., Wong, W. T., Chew, E. Y., & Lu, Z. (2019) · Ophthalmology · doi:10.1016/j.ophtha.2018.11.015 · Cited by 349
Self-citationAge-Related Macular Degeneration Preferred Practice Pattern®
Flaxel, C. J., Adelman, R. A., Bailey, S. T., Fawzi, A., Lim, J. I., Vemulakonda, G. A., & Ying, G.-S. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2019.09.024 · Cited by 349
OCT angiography and evaluation of the choroid and choroidal vascular disorders
Borrelli, E., Sarraf, D., Freund, K. B., & Sadda, S. R. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.07.002 · Cited by 321
Self-citationSoft Drusen in Age-Related Macular Degeneration: Biology and Targeting Via the Oil Spill Strategies
Curcio, C. A. (2018) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.18-24882 · Cited by 318
Incomplete Retinal Pigment Epithelial and Outer Retinal Atrophy in Age-Related Macular Degeneration
Guymer, R. H., Rosenfeld, P. J., Curcio, C. A., Holz, F. G., Staurenghi, G., Freund, K. B., Schmitz-Valckenberg, S., Sparrow, J., Spaide, R. F., Tufail, A., et al. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2019.09.035 · Cited by 316
Self-citationYehoshua, Z., Alexandre de Amorim Garcia Filho, C., Nunes, R. P., Gregori, G., Penha, F. M., Moshfeghi, A. A., Zhang, K., Sadda, S., Feuer, W., & Rosenfeld, P. J. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.09.044 · Cited by 299
Self-citationSubretinal drusenoid deposits AKA pseudodrusen
Spaide, R. F., Ooto, S., & Curcio, C. A. (2018) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2018.05.005 · Cited by 292
Taylor, D. J., Hobby, A. E., Binns, A. M., & Crabb, D. P. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011504 · Cited by 288
Dry Age-Related Macular Degeneration: Mechanisms, Therapeutic Targets, and Imaging
Bowes Rickman, C., Farsiu, S., Toth, C. A., & Klingeborn, M. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-12757 · Cited by 282
Cholesterol in the retina: The best is yet to come
Pikuleva, I. A., & Curcio, C. A. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.03.002 · Cited by 281
Prevalence of Age-Related Macular Degeneration in the US in 2019
Rein, D. B., Wittenborn, J. S., Burke-Conte, Z., Gulia, R., Robalik, T., Ehrlich, J. R., Lundeen, E. A., & Flaxman, A. D. (2022) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2022.4401 · Cited by 275
The Diagnosis and Treatment of Age-Related Macular Degeneration
Stahl, A. (2020) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2020.0513 · Cited by 270
Wu, Z., Luu, C. D., Ayton, L. N., Goh, J. K., Lucci, L. M., Hubbard, W. C., Hageman, J. L., Hageman, G. S., & Guymer, R. H. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.06.034 · Cited by 264
Boyer, D. S., Schmidt-Erfurth, U., van Lookeren Campagne, M., Henry, E. C., & Brittain, C. (2017) · Retina · doi:10.1097/iae.0000000000001392 · Cited by 258
The Integration of Artificial Intelligence into Clinical Practice
Karalis, V. D. (2024) · Applied Biosciences · doi:10.3390/applbiosci3010002 · Cited by 255
“Age-related macular degeneration is a chronic ocular condition that is recognized as a prominent contributor to visual impairment [134].”
BackgroundA new perspective on lipid research in age-related macular degeneration
van Leeuwen, E. M., Emri, E., Merle, B. M. J., Colijn, J. M., Kersten, E., Cougnard-Gregoire, A., Dammeier, S., Meester-Smoor, M., Pool, F. M., de Jong, E. K., et al. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.04.006 · Cited by 247
Clinical applications of fundus autofluorescence in retinal disease
Yung, M., Klufas, M. A., & Sarraf, D. (2016) · International Journal of Retina and Vitreous · doi:10.1186/s40942-016-0035-x · Cited by 236
Zanzottera, E. C., Messinger, J. D., Ach, T., Smith, R. T., Freund, K. B., & Curcio, C. A. (2015) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.15-16431 · Cited by 164
Exploiting epistemic uncertainty of anatomy segmentation for anomaly detection in retinal OCT
Seebock, P., Orlando, J. I., Schlegl, T., Waldstein, S. M., Bogunovic, H., Klimscha, S., Langs, G., & Schmidt-Erfurth, U. (2020) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2019.2919951 · Cited by 164
“According to the Beckman Initiative Classification [31], we allowed drusen below 63 μm in size as only visible alteration, as they normally do not result in visual impairment.”
MethodWinkler, T. W., Grassmann, F., Brandl, C., Kiel, C., Günther, F., Strunz, T., Weidner, L., Zimmermann, M. E., Korb, C. A., Poplawski, A., et al. (2020) · BMC Medical Genomics · doi:10.1186/s12920-020-00760-7 · Cited by 138
Deletion of autophagy inducer RB1CC1 results in degeneration of the retinal pigment epithelium
Yao, J., Jia, L., Khan, N., Lin, C., Mitter, S. K., Boulton, M. E., Dunaief, J. L., Klionsky, D. J., Guan, J.-L., Thompson, D. A., et al. (2015) · Autophagy · doi:10.1080/15548627.2015.1041699 · Cited by 130
The challenges and promise of complement therapeutics for ocular diseases
Park, D. H., Connor, K. M., & Lambris, J. D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01007 · Cited by 108
Notomi, S., Ishihara, K., Efstathiou, N. E., Lee, J.-J., Hisatomi, T., Tachibana, T., Konstantinou, E. K., Ueta, T., Murakami, Y., Maidana, D. E., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1906643116 · Cited by 92
Immunological aspects of RPE cell transplantation
Sugita, S., Mandai, M., Kamao, H., & Takahashi, M. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100950 · Cited by 77
More than meets the eye: The role of microglia in healthy and diseased retina
Murenu, E., Gerhardt, M.-J., Biel, M., & Michalakis, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1006897 · Cited by 73
Callanan, D., Kunimoto, D., Maturi, R. K., Patel, S. S., Staurenghi, G., Wolf, S., Cheetham, J. K., Hohman, T. C., Kim, K., López, F. J., et al. (2018) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2018.0062 · Cited by 73
Coughlin, B., Schnabolk, G., Joseph, K., Raikwar, H., Kunchithapautham, K., Johnson, K., Moore, K., Wang, Y., & Rohrer, B. (2016) · Scientific Reports · doi:10.1038/srep23794 · Cited by 65
Maurya, M., Bora, K., Blomfield, A. K., Pavlovich, M. C., Huang, S., Liu, C.-H., & Chen, J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.369098 · Cited by 63
“Currently, the size of drusen serves as a classification marker of the clinical progression or worsening of AMD (Ferris et al., 2013).”
Lamin, A., Oakley, J. D., Dubis, A. M., Russakoff, D. B., & Sivaprasad, S. (2019) · Eye · doi:10.1038/s41433-018-0234-9 · Cited by 57
Dow, C. T., & Harley, C. (2016) · Clinical Ophthalmology · doi:10.2147/opth.s100042 · Cited by 56
Fraccaro, P., Nicolo, M., Bonetto, M., Giacomini, M., Weller, P., Traverso, C. E., Prosperi, M., & OSullivan, D. (2015) · BMC Ophthalmology · doi:10.1186/1471-2415-15-10 · Cited by 48
“Primary diagnosis (AMD or other macular diseases); Relevant clinical signs [12] identified by clinicians during the visit as binary variables (positive if identified): o Soft drusen; o Retinal Pigment Epitelium (RPE) defects/pigment mottling; o Depigmentation area(s); o Subretinal haemorrhage; o Subretinal fluid; o Ma…”
Alshamrani, M., Sikder, S., Coulibaly, F., Mandal, A., Pal, D., & Mitra, A. K. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-019-1404-1 · Cited by 46
Lynch, A. M., Mandava, N., Patnaik, J. L., Frazer-Abel, A. A., Wagner, B. D., Palestine, A. G., Mathias, M. T., Siringo, F. S., Cathcart, J. N., & Holers, V. M. (2020) · European Journal of Ophthalmology · doi:10.1177/1120672119857896 · Cited by 44
Retinal Progression Biomarkers of Early and Intermediate Age-Related Macular Degeneration
Flores, R., Carneiro, Â., Tenreiro, S., & Seabra, M. C. (2021) · Life · doi:10.3390/life12010036 · Cited by 42
Ruiz-Moreno, J. M., Arias, L., Abraldes, M. J., Montero, J., Udaondo, P., & The RAMDEBURS study group (2021) · International Ophthalmology · doi:10.1007/s10792-021-01906-x · Cited by 41
Biarnés, M., Colijn, J. M., Sousa, J., Ferraro, L. L., Garcia, M., Verzijden, T., Meester-Smoor, M. A., Delcourt, C., Klaver, C. C. W., den Hollander, A. I., et al. (2020) · Ophthalmology Retina · doi:10.1016/j.oret.2020.04.014 · Cited by 40
Complement inhibitors for age-related macular degeneration
Tzoumas, N., Riding, G., Williams, M. A., & Steel, D. H. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009300.pub3 · Cited by 38
Trinh, M., Kalloniatis, M., Alonso-Caneiro, D., & Nivison-Smith, L. (2022) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.63.5.36 · Cited by 29
Longitudinal Changes in Retinotopic Rod Function in Intermediate Age-Related Macular Degeneration
Nguyen, C. T., Fraser, R. G., Tan, R., Caruso, E., Lek, J. J., Guymer, R. H., & Luu, C. D. (2018) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.17-23084 · Cited by 32
Lee, S., Kang, I. K., Kim, J. H., Jung, B. K., Park, K., Chang, H., Lee, J. Y., & Lee, H. (2019) · Translational Vision Science & Technology · doi:10.1167/tvst.8.2.14 · Cited by 27
Trinh, M., Khou, V., Kalloniatis, M., & Nivison-Smith, L. (2021) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.62.13.13 · Cited by 14
Making Biological Sense of Genetic Studies of Age-Related Macular Degeneration
Singh, N., Swaroop, A., & Ratnapriya, R. (2021) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-66014-7_8 · Cited by 11
Dev, M. K., Black, A. A., Cuda, D., & Wood, J. M. (2022) · Translational Vision Science & Technology · doi:10.1167/tvst.11.3.21 · Cited by 10
Wright, D. M., Chakravarthy, U., Das, R., Graham, K. W., Naskas, T. T., Perais, J., Kee, F., Peto, T., & Hogg, R. E. (2023) · Diabetologia · doi:10.1007/s00125-023-06005-3 · Cited by 10
Self-citationElevated Prevalence of Age‐Related Macular Degeneration in a Low‐Income Urban Primary Care Setting
Kaganovski, A., Bhuiyan, A., Kasi, A., Kamyab, D., Grinberg, A., Chen, S., Thomson, R., Bhuiyan, T., Govindaiah, A., Deobhakta, A., et al. (2026) · Discover Public Health · doi:10.1186/s12982-026-01672-0 · Cited by 1
“…were classified as having referable AMD, based on the Beckman classification, if fundus images revealed intermediate AMD (large drusen > 125 microns, or pigmentary abnormalities and medium drusen ≥ 63- 125 microns) or late AMD (lesions associated with neovascular AMD or geographic atrophy) [6].”
Metadata
- Authors
- Ferris, F. L., Wilkinson, C. P., Bird, A., Chakravarthy, U., Chew, E., Csaky, K., & Sadda, S. R.
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2013-04
- Volume
- 120
- Issue
- 4
- Pages
- 844-851
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W1972642682
- Cited by
- 1,863
- References
- 18
- FWCI
- 62.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.